News

FDA approves first twice-yearly injection that prevents HIV infection
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
The Manila Times11m
HIV-prevention drug wins FDA approval
THE United States Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences' lenacapavir, a drug to be injected twice annually, for preventing HIV infection in adults and adolescents at ...
Medical Dialogues47m
FDA Approves First Twice-Yearly Injectable PrEP for HIV Prevention
The US Food and Drug Administration has approved lenacapavir (Yeztugo), the first twice-yearly injectable HIV-1 prevention ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...